Cargando…
Comparative profiling of immune genes improves the prognoses of lower grade gliomas
OBJECTIVE: Lower grade gliomas (LGGs), classified as World Health Organization (WHO) grade II and grade III gliomas, comprise a heterogeneous group with a median survival time ranging from 4–13 years. Accurate prediction of the survival times of LGGs remains a major challenge in clinical practice. M...
Autores principales: | Wang, Zhiliang, Cheng, Wen, Zhao, Zheng, Wang, Zheng, Zhang, Chuanbao, Li, Guanzhang, Wu, Anhua, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088193/ https://www.ncbi.nlm.nih.gov/pubmed/34623790 http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0173 |
Ejemplares similares
-
Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018) -
Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
por: Wang, Zheng, et al.
Publicado: (2016) -
FGFR3, as a receptor tyrosine kinase, is associated with differentiated biological functions and improved survival of glioma patients
por: Wang, Zheng, et al.
Publicado: (2016) -
ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas
por: Fan, Xing, et al.
Publicado: (2016) -
Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas
por: Zhao, Zheng, et al.
Publicado: (2017)